Theranexus : THERANEXUS PUBLISHES ITS 2023 FULL-YEAR R

Lyon, France – 29 April 2024 – 6pm CET – Theranexus, a biopharmaceutical company innovating in the treatment of rare neurological diseases, today publishes its results for the year ending 31...

Related Keywords

Paris , France General , France , Portejoie , Haute Normandie , United States , American , French , Mathieu Charv , Thierry Lambert , Inserm Transfert , American Beyond Batten Disease Foundation , Drug Administration , Research Tax Credit , Kedge Business School , Claude Bernard University Lyon , Atomic Energy Commission , Access Program , European Medicines Agency , Young , Linkedin , Twitter , Theranexus Chairman , Tax Credit , Christine Placet , Chief Financial , Chief Financial Officer , Coave Therapeutics , Kedge Business , Expanded Access Program , French Alternative Energies , Euronext Growth , Markets ,